Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

CarboMed licenses broad-spectrum anticancer agent to Zeneca

July 8, 1997

QLT PhotoTherapeutics files for Canadian approval of lung cancer treatment

July 8, 1997

MRC initiates trial to improve survival of patients with resectable NSCLC

July 8, 1997

Troponin I inhibits breast cancer growth in preclinical trial

July 8, 1997

Navelbine introduced in the U.K.

July 8, 1997

Update on DepoTech's DepoCyt

July 8, 1997

Sanwa Kagaku characterizes analogues of dynemicin A

July 8, 1997

Double identity of Bcl-2 protein described

July 7, 1997

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

July 7, 1997

Sugen files IND for angiogenesis inhibitor

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.